BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 23640890)

  • 1. Erythrocytosis and pulmonary hypertension in a mouse model of human HIF2A gain of function mutation.
    Tan Q; Kerestes H; Percy MJ; Pietrofesa R; Chen L; Khurana TS; Christofidou-Solomidou M; Lappin TR; Lee FS
    J Biol Chem; 2013 Jun; 288(24):17134-44. PubMed ID: 23640890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythrocytosis-associated HIF-2alpha mutations demonstrate a critical role for residues C-terminal to the hydroxylacceptor proline.
    Furlow PW; Percy MJ; Sutherland S; Bierl C; McMullin MF; Master SR; Lappin TR; Lee FS
    J Biol Chem; 2009 Apr; 284(14):9050-8. PubMed ID: 19208626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythrocytosis associated with a novel missense mutation in the HIF2A gene.
    van Wijk R; Sutherland S; Van Wesel AC; Huizinga EG; Percy MJ; Bierings M; Lee FS
    Haematologica; 2010 May; 95(5):829-32. PubMed ID: 20007141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A knock-in mouse model of human PHD2 gene-associated erythrocytosis establishes a haploinsufficiency mechanism.
    Arsenault PR; Pei F; Lee R; Kerestes H; Percy MJ; Keith B; Simon MC; Lappin TRJ; Khurana TS; Lee FS
    J Biol Chem; 2013 Nov; 288(47):33571-33584. PubMed ID: 24121508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital erythrocytosis associated with gain-of-function HIF2A gene mutations and erythropoietin levels in the normal range.
    Perrotta S; Stiehl DP; Punzo F; Scianguetta S; Borriello A; Bencivenga D; Casale M; Nobili B; Fasoli S; Balduzzi A; Cro L; Nytko KJ; Wenger RH; Della Ragione F
    Haematologica; 2013 Oct; 98(10):1624-32. PubMed ID: 23716564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on mutations in the HIF: EPO pathway and their role in erythrocytosis.
    Lappin TR; Lee FS
    Blood Rev; 2019 Sep; 37():100590. PubMed ID: 31350093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The HIF pathway and erythrocytosis.
    Lee FS; Percy MJ
    Annu Rev Pathol; 2011; 6():165-92. PubMed ID: 20939709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel exon 12 mutations in the HIF2A gene associated with erythrocytosis.
    Percy MJ; Beer PA; Campbell G; Dekker AW; Green AR; Oscier D; Rainey MG; van Wijk R; Wood M; Lappin TR; McMullin MF; Lee FS
    Blood; 2008 Jun; 111(11):5400-2. PubMed ID: 18378852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A gain-of-function mutation in the HIF2A gene in familial erythrocytosis.
    Percy MJ; Furlow PW; Lucas GS; Li X; Lappin TR; McMullin MF; Lee FS
    N Engl J Med; 2008 Jan; 358(2):162-8. PubMed ID: 18184961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JNK2 up-regulates hypoxia-inducible factors and contributes to hypoxia-induced erythropoiesis and pulmonary hypertension.
    Sala MA; Chen C; Zhang Q; Do-Umehara HC; Wu W; Misharin AV; Waypa GB; Fang D; Budinger GRS; Liu S; Chandel NS; Schumacker PT; Sznajder JI; Liu J
    J Biol Chem; 2018 Jan; 293(1):271-284. PubMed ID: 29118187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic inhibition of HIF-2α reverses polycythemia and pulmonary hypertension in murine models of human diseases.
    Ghosh MC; Zhang DL; Ollivierre WH; Noguchi A; Springer DA; Linehan WM; Rouault TA
    Blood; 2021 May; 137(18):2509-2519. PubMed ID: 33512384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel biological function of soluble biglycan: Induction of erythropoietin production and polycythemia.
    Frey H; Moreth K; Hsieh LT; Zeng-Brouwers J; Rathkolb B; Fuchs H; Gailus-Durner V; Iozzo RV; de Angelis MH; Schaefer L
    Glycoconj J; 2017 Jun; 34(3):393-404. PubMed ID: 27600268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polycythemia and paraganglioma with a novel somatic HIF2A mutation in a male.
    Toyoda H; Hirayama J; Sugimoto Y; Uchida K; Ohishi K; Hirayama M; Komada Y
    Pediatrics; 2014 Jun; 133(6):e1787-91. PubMed ID: 24819565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIF-1α is a protective factor in conditional PHD2-deficient mice suffering from severe HIF-2α-induced excessive erythropoiesis.
    Franke K; Kalucka J; Mamlouk S; Singh RP; Muschter A; Weidemann A; Iyengar V; Jahn S; Wieczorek K; Geiger K; Muders M; Sykes AM; Poitz DM; Ripich T; Otto T; Bergmann S; Breier G; Baretton G; Fong GH; Greaves DR; Bornstein S; Chavakis T; Fandrey J; Gassmann M; Wielockx B
    Blood; 2013 Feb; 121(8):1436-45. PubMed ID: 23264599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. von Hippel-Lindau mutation in mice recapitulates Chuvash polycythemia via hypoxia-inducible factor-2alpha signaling and splenic erythropoiesis.
    Hickey MM; Lam JC; Bezman NA; Rathmell WK; Simon MC
    J Clin Invest; 2007 Dec; 117(12):3879-89. PubMed ID: 17992257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of oxygen-sensing pathways in physiologic and pathologic erythropoiesis.
    Semenza GL
    Blood; 2009 Sep; 114(10):2015-9. PubMed ID: 19494350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Endothelial Prolyl-4-Hydroxylase Domain 2/Hypoxia-Inducible Factor 2 Axis Regulates Pulmonary Artery Pressure in Mice.
    Kapitsinou PP; Rajendran G; Astleford L; Michael M; Schonfeld MP; Fields T; Shay S; French JL; West J; Haase VH
    Mol Cell Biol; 2016 May; 36(10):1584-94. PubMed ID: 26976644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Notch Downregulation and Extramedullary Erythrocytosis in Hypoxia-Inducible Factor Prolyl 4-Hydroxylase 2-Deficient Mice.
    Myllymäki MNM; Määttä J; Dimova EY; Izzi V; Väisänen T; Myllyharju J; Koivunen P; Serpi R
    Mol Cell Biol; 2017 Jan; 37(2):. PubMed ID: 27821476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of Erythropoiesis by the Hypoxia-Inducible Factor Pathway: Effects of Genetic and Pharmacological Perturbations.
    Semenza GL
    Annu Rev Med; 2023 Jan; 74():307-319. PubMed ID: 35773226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between serum concentrations of hypoxia inducible factor responsive proteins and excessive erythrocytosis in high altitude Peru.
    Painschab MS; Malpartida GE; Dávila-Roman VG; Gilman RH; Kolb TM; León-Velarde F; Miranda JJ; Checkley W
    High Alt Med Biol; 2015 Mar; 16(1):26-33. PubMed ID: 25760230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.